Skip to main content
TipRanks
Go Ultimate75% OFF

Jon Sakoda Insider Profile

4 Followers

Jon Sakoda, Ten Percent Owner at Ardelyx, holds 17.78M shares in AVEO Pharma (Ticker: AVEO), holds 6.16M shares in Ardelyx (Ticker: ARDX), holds 0.00 shares in Cascadian Therapeutics (Ticker: CASC). Most recently, Jon Sakoda Bought ― shares of AVEO Pharma on Jun 28, 2018 for an estimated value of $402.49K.

Jon Sakoda's Trading History

AVEO
AVEO Pharma
Jun 28, 2018―Informative Buy402.49K$266.76M
ARDX
Ardelyx
May 30, 2018Ten Percent OwnerUninformative Buy3.33M$19.05M
CASC
Cascadian Therapeutics
Mar 13, 2018―Uninformative Sell―$0.00
ORKA
Oruka Therapeutics
Feb 27, 2018Ten Percent OwnerInformative Sell730.10K$0.00
RGLS
Regulus
Jul 31, 2017―Informative Buy―$89.67M
AKAOQ
Achaogen
Dec 19, 2016―Informative Buy6.75M$117.88K
OPWR
Opower
May 29, 2015―Uninformative Buy―$196.01K

You May Also Like

Jon Sakoda insider profile FAQ

What is the percentage of profitable transactions made by Jon Sakoda?
The percentage of profitable transactions made by Jon Sakoda is 31%.
What is the average return per transaction made by Jon Sakoda?
The average return per transaction made by Jon Sakoda is 25.60%.
What stocks does Jon Sakoda hold?
Jon Sakoda holds: ARDX, ORKA, AVEO, CASC, RGLS, AKAOQ, OPWR stocks.
What was Jon Sakoda’s latest transaction?
Jon Sakoda’s latest transaction was an Informative Buy of $402.49K.
What was Jon Sakoda's most profitable transaction?
Jon Sakoda’s most profitable transaction was an Informative Buy of AKAOQ stock on June 7, 2016. The return on the trade was 423.70%.
What is Jon Sakoda's role in Ardelyx?
Jon Sakoda's role in Ardelyx is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.